{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:32:11Z","timestamp":1769171531435,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Limited evidence is available regarding the role of high-flow nasal oxygen in the management of acute hypoxemic respiratory failure secondary to coronavirus disease 2019. Our objective was to characterize outcomes associated with high-flow nasal oxygen use in critically ill adult patients with coronavirus disease 2019-associated acute hypoxemic respiratory failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Observational cohort study between March 18, 2020, and June 3, 2020.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Nine ICUs at three university-affiliated hospitals in Philadelphia, PA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Adult ICU patients with confirmed coronavirus disease 2019 infection admitted with acute hypoxemic respiratory failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Of 266 coronavirus disease 2019 ICU admissions during the study period, 124 (46.6%) received some form of noninvasive respiratory support. After exclusions, we analyzed 83 patients who were treated with high-flow nasal oxygen as a first-line therapy at or near the time of ICU admission. Patients were predominantly male (63.9%). The most common comorbidity was hypertension (60.2%). Progression to invasive mechanical ventilation was common, occurring in 58 patients (69.9%). Of these, 30 (51.7%) were intubated on the same day as ICU admission. As of June 30, 2020, hospital mortality rate was 32.9% and the median hospital length of stay was 15 days. Among survivors, the most frequent discharge disposition was home (51.0%). In comparing patients who received high-flow nasal oxygen alone (<jats:italic toggle=\"yes\">n<\/jats:italic> = 54) with those who received high-flow nasal oxygen in conjunction with noninvasive positive-pressure ventilation via face mask (<jats:italic toggle=\"yes\">n<\/jats:italic> = 29), there were no differences in the rates of endotracheal intubation or other clinical and utilization outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>We observed an overall high usage of high-flow nasal oxygen in our cohort of critically ill patients with acute hypoxemic respiratory failure secondary to coronavirus disease 2019. Rates of endotracheal intubation and mortality in this cohort were on par with and certainly not higher than other published series. These findings should prompt further considerations regarding the use of high-flow nasal oxygen in the management algorithm for coronavirus disease 2019-associated acute hypoxemic respiratory failure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000257","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T13:06:03Z","timestamp":1603199163000},"page":"e0257","source":"Crossref","is-referenced-by-count":3,"title":["The Use of High-Flow Nasal Oxygen in the ICU as a First-Line Therapy for Acute Hypoxemic Respiratory Failure Secondary to Coronavirus Disease 2019"],"prefix":"10.1097","volume":"2","author":[{"given":"Gregory","family":"McDonough","sequence":"first","affiliation":[{"name":"Department of Medicine, Thomas Jefferson University, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phue","family":"Khaing","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas Jefferson University, Philadelphia, PA."},{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Treacy","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"McGrath","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas Jefferson University, Philadelphia, PA."},{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika J.","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas Jefferson University, Philadelphia, PA."},{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"R1-20231023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13613-020-00692-6","article-title":"Caution about early intubation and mechanical ventilation in COVID-19.","volume":"10","author":"Tobin","year":"2020","journal-title":"Ann Intensive Care"},{"key":"R2-20231023","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13054-020-03063-6","article-title":"A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure.","volume":"24","author":"Villarreal-Fernandez","year":"2020","journal-title":"Crit Care"},{"key":"R3-20231023","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19).","volume":"46","author":"Alhazzani","year":"2020","journal-title":"Intensive Care Med"},{"key":"R4-20231023","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2016.14194","article-title":"Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: A randomized clinical trial.","volume":"316","author":"Hern\u00e1ndez","year":"2016","journal-title":"JAMA"},{"key":"R5-20231023","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1164\/rccm.201402-0364OC","article-title":"Nasal high-flow versus venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome.","volume":"190","author":"Maggiore","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20231023","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"key":"R7-20231023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13613-020-00653-z","article-title":"The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China.","volume":"10","author":"Wang","year":"2020","journal-title":"Annals Intensive Care"},{"key":"R8-20231023","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study.","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"key":"R9-20231023","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R10-20231023","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1001\/jama.288.17.2151","article-title":"Physician staffing patterns and clinical outcomes in critically ill patients: A systematic review.","volume":"288","author":"Pronovost","year":"2002","journal-title":"JAMA"},{"key":"R11-20231023","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R12-20231023","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.202003-0736LE","article-title":"Clinical course and outcomes of 344 intensive care patients with COVID-19.","volume":"201","author":"Wang","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20231023","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy.","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"R14-20231023","article-title":"ICU and ventilator mortality among critically ill adults with coronavirus disease 2019 [published online ahead of print May 26, 2020]","author":"Auld","journal-title":"Crit Care Med"},{"key":"R15-20231023","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically Ill patients in the Seattle region - case series.","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N Engl J Med"},{"key":"R16-20231023","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"R17-20231023","first-page":"200","article-title":"Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy.","volume":"22","author":"Zangrillo","year":"2020","journal-title":"Crit Care Resusc"},{"key":"R18-20231023","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2018.14282","article-title":"Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: The HIGH randomized clinical trial.","volume":"320","author":"Azoulay","year":"2018","journal-title":"JAMA"},{"key":"R19-20231023","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/1742-6723.12490","article-title":"Randomised control trial of humidified high flow nasal cannulae versus standard oxygen in the emergency department.","volume":"27","author":"Bell","year":"2015","journal-title":"Emerg Med Australas"},{"key":"R20-20231023","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.annemergmed.2017.12.006","article-title":"High-velocity nasal insufflation in the treatment of respiratory failure: A randomized clinical trial.","volume":"72","author":"Doshi","year":"2018","journal-title":"Ann Emerg Med"},{"key":"R21-20231023","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4187\/respcare.04252","article-title":"Randomized controlled trial of humidified high-flow nasal oxygen for acute respiratory distress in the emergency department: The HOT-ER study.","volume":"61","author":"Jones","year":"2016","journal-title":"Respir Care"},{"key":"R22-20231023","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-015-1097-0","article-title":"The effects of a 2-h trial of high-flow oxygen by nasal cannula versus venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: A multicenter randomized trial.","volume":"19","author":"Lemiale","year":"2015","journal-title":"Crit Care"},{"key":"R23-20231023","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2020.9524","article-title":"Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: A systematic review and meta-analysis.","volume":"324","author":"Ferreyro","year":"2020","journal-title":"JAMA"},{"key":"R24-20231023","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: Different respiratory treatments for different phenotypes?","volume":"46","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med"},{"key":"R25-20231023","doi-asserted-by":"crossref","first-page":"2002135","DOI":"10.1183\/13993003.02135-2020","article-title":"COVID-19 conundrum: Clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness.","volume":"56","author":"Cheria","year":"2020","journal-title":"Eur Respir J"},{"key":"R26-20231023","doi-asserted-by":"crossref","first-page":"2000892","DOI":"10.1183\/13993003.00892-2020","article-title":"High-flow nasal cannula for COVID-19 patients: Low risk of bio-aerosol dispersion.","volume":"55","author":"Li","year":"2020","journal-title":"Eur Respiratory J"},{"key":"R27-20231023","article-title":"High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: Systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission [published online ahead of print June 15, 2020]","author":"Agarwal","journal-title":"Can J Anesth"},{"key":"R28-20231023","doi-asserted-by":"crossref","first-page":"e209666","DOI":"10.1001\/jamanetworkopen.2020.9666","article-title":"Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China.","volume":"3","author":"Lai","year":"2020","journal-title":"JAMA Network Open"},{"key":"R29-20231023","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4187\/respcare.03075","article-title":"Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: An observational pilot study.","volume":"60","author":"Frat","year":"2015","journal-title":"Respir Care"},{"key":"R30-20231023","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1164\/rccm.201605-1081CP","article-title":"Mechanical ventilation to minimize progression of lung injury in acute respiratory failure.","volume":"195","author":"Brochard","year":"2017","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T17:07:14Z","timestamp":1698080834000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000257","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}